Regulation of p53 protein function through alterations in protein-folding pathways
- PMID: 10065154
- PMCID: PMC11146786
- DOI: 10.1007/s000180050272
Regulation of p53 protein function through alterations in protein-folding pathways
Abstract
The tumour suppressor protein p53 is a stress-activated transcription factor whose activity is required for regulating the cellular response to stress and damage. The biochemical activity of p53 as a transcription factor can be regulated by partner proteins affecting stability, nuclear transport, signalling pathways modulating phosphorylation and interactions with components of the transcriptional machinery. The key structural determinants of p53 protein that drive sequence-specific DNA binding include the core specific DNA-binding domain and the tetramerization domain. Flanking these domains are more evolutionarily divergent carboxy- and amino-terminal regulatory motifs that further modulate tetramerization and sequence-specific transactivation. This review will mainly focus on the mechanisms whereby the tetramerization domain modulates sequence-specific DNA binding and how missense point mutations in p53 protein and the activity of molecular chaperones may lead to unfolding of mutant p53 tetramers in human tumours.
Similar articles
-
p53 tetramerization: at the center of the dominant-negative effect of mutant p53.Genes Dev. 2020 Sep 1;34(17-18):1128-1146. doi: 10.1101/gad.340976.120. Genes Dev. 2020. PMID: 32873579 Free PMC article. Review.
-
Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.J Mol Biol. 2001 Nov 2;313(4):711-31. doi: 10.1006/jmbi.2001.5082. J Mol Biol. 2001. PMID: 11697899
-
Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.PLoS One. 2016 Jan 7;11(1):e0144284. doi: 10.1371/journal.pone.0144284. eCollection 2016. PLoS One. 2016. PMID: 26742101 Free PMC article.
-
The R337C mutation in the p53 oligomerization domain affects the regulatory domain and its ability to bind response elements: Evidence based on structural and biophysical studies.Arch Biochem Biophys. 2025 Jun;768:110381. doi: 10.1016/j.abb.2025.110381. Epub 2025 Mar 8. Arch Biochem Biophys. 2025. PMID: 40064360
-
Signaling to p53: breaking the posttranslational modification code.Pathol Biol (Paris). 2000 Apr;48(3):227-45. Pathol Biol (Paris). 2000. PMID: 10858956 Review.
Cited by
-
Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA.Mol Cancer Ther. 2012 Oct;11(10):2243-53. doi: 10.1158/1535-7163.MCT-12-0135. Epub 2012 Aug 28. Mol Cancer Ther. 2012. PMID: 22933706 Free PMC article.
-
Activation of p53 protein by telomeric (TTAGGG)n repeats.Nucleic Acids Res. 2001 Dec 15;29(24):5207-15. doi: 10.1093/nar/29.24.5207. Nucleic Acids Res. 2001. PMID: 11812854 Free PMC article.
-
Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets.Nucleic Acids Res. 2011 Mar;39(5):1919-32. doi: 10.1093/nar/gkq1044. Epub 2010 Nov 10. Nucleic Acids Res. 2011. PMID: 21071400 Free PMC article.
-
Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.Nucleic Acids Res. 2002 Nov 15;30(22):4966-74. doi: 10.1093/nar/gkf616. Nucleic Acids Res. 2002. PMID: 12434001 Free PMC article.
-
Anticancer Therapeutic Strategies Targeting p53 Aggregation.Int J Mol Sci. 2022 Sep 20;23(19):11023. doi: 10.3390/ijms231911023. Int J Mol Sci. 2022. PMID: 36232329 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous